Viewing nowRovide 10mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
CTC Bio, Co., Ltd.

MFDS item code 201507897 · Approved 2015.11.25 · Insurance code 669501700
Improves dyslipidemia, inhibits the progression of atherosclerosis, and reduces the risk of cardiovascular disease
This medication is used for the treatment of hypercholesterolemia and mixed dyslipidemia. It is used as an adjunct when dietary changes and exercise are insufficient and is particularly effective in patients with familial hypercholesterolemia. It helps lower total cholesterol and LDL-cholesterol, delaying the progression of atherosclerosis and reducing the risk of cardiovascular events. Additionally, it may be used as an adjunct in pediatric patients of certain ages to reduce cholesterol levels. It also has a beneficial effect in reducing the risk of cardiovascular events such as myocardial infarction and stroke. Overall, it is used to improve cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled with this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administration of doses greater than 20 milligrams in pediatric patients.) Safety and efficacy in children under 10 years of age have not been established.
This medication should not be used in certain patients. For example, patients with allergies to any of its components or those with severely impaired liver function should avoid its use. Moreover, patients with muscle disorders, those taking cyclosporine, and those with severe renal impairment should not take this medication. Pregnant or nursing women, and fertile women who do not use adequate contraception should consult a doctor before using this drug. In particular, patients at higher risk of muscle disorders should avoid high doses, and patients with certain genetic issues such as lactose intolerance should also not take this medication. Regular monitoring of liver function and muscle status is required while taking this medication. Patients who consume excessive alcohol or have a history of liver disease need to be particularly cautious. If symptoms such as myalgia or muscle weakness occur, they should immediately inform healthcare professionals and discontinue use if necessary. Additionally, use should also be discontinued in cases of severe acute illness or symptoms of severe muscle weakness. This medication may interact with other drugs, so if you are taking other medications, you must inform your doctor or pharmacist. Particularly, when used with certain antiviral drugs, immunosuppressants, antibiotics, and fibrate medications, the risk of muscle adverse reactions may increase. Pregnant or nursing women should not use this drug, and women of childbearing potential should use appropriate contraception before taking it. This is due to the potential risks it may pose to fetuses and infants. In cases of overdose, there is no specific antidote, thus treatment according to symptoms, along with testing of liver function and muscle enzymes is needed. This medication is not known to affect driving or operating machinery, but caution is advised due to the possibility of dizziness. Finally, this drug may rarely cause severe skin reactions, liver dysfunction, and myopathy in some patients, so it is important to consult healthcare professionals immediately if any abnormal symptoms occur.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, morbilliform drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, arthralgia, fatigue, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container, protected from air and moisture, and it is important to maintain storage temperatures between 1°C and 30°C. Proper storage will help preserve the medication's efficacy and prevent degradation.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
CTC Bio, Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.